PDCD4 and breast carcinoma: In addition to miR-21, miR-17-5p (52), miR-206 (53), miR-183-5p (54), miR-421 (28) and miR-424 (55) were reported to inhibit PDCD4 expression to influence the malignant behaviors of breast cancer cells (56).